RE:RE:I GOT THIS POST FROM CEO.CA TODAY!The charts say otherwise. Like weed stocks and more recently gold stocks, shares in companies touting covid relief have their initial bump ups. Depending on the stock sector it is, not surprisingly there will be a slow, if not general, trend down until concrete news is available. Some have complained about "the fluff" but most investors aren't biology literate and so the company releases info that doesn't result in the SP flying up but gives some indication that work is progressing. The fact that the downward trend for Thrm has been a drip, to use your words, is actually a positive sign. Couple that with shares and warrants ranging from $.05 to $.22 and there is nothing exceptional here ....except for the potential for some very good news based on the expertise of some very talented researchers.
As for the delay, science/biology is not some easily predetermined venture. this virus is unique and as such requires a thorough understanding. Based on experience they chose a 45 day timeframe ...it wasn't cast in stone, nor should it have been.
Concerning ones virtual identity, I'm glad Saeid Babaei is not concerned about his Linkedin Account. When you consider what he's been doing over the last two years (and more) there is no reason for an update.